Expression of lambda int gene function in ColE1 hybrid plasmids carrying the C fragment of bacteriophage lambda.

Site-specific recombination functions of bacteriophage lambda: DNA sequence of regulatory regions and overlapping structural genes for Int and Xis. Proc Natl Acad Sci U S A (1980) 3.08

DNA sequence of regulatory region for integration gene of bacteriophage lambda. Proc Natl Acad Sci U S A (1980) 1.36

Isolation, characterization, and sequence of an Escherichia coli heat shock gene, htpX. J Bacteriol (1991) 1.13

EK2 derivatives of bacteriophage lambda useful in the cloning of DNA from higher organisms: the lambdagtWES system. Science (1977) 13.24

In vitro packaging of a lambda Dam vector containing EcoRI DNA fragments of Escherichia coli and phage P1. Gene (1977) 10.75

DNA sequence required for initiation of transcription in vitro from the major late promoter of adenovirus 2. Proc Natl Acad Sci U S A (1981) 9.08

Mapping of deletions and substitutions in heteroduplex DNA molecules of bacteriophage lambda by electron microscopy. Science (1969) 5.54

Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein. Lancet (1991) 5.42

Nomenclature of transposable elements in prokaryotes. Gene (1979) 4.13

Microbial Selection. Science (1952) 4.08

Physicochemical properties of complexes between deoxyribonucleic acid and antibiotics which affect ribonucleic acid synthesis (actinomycin, daunomycin, cinerubin, nogalamycin, chormomycin, mithramycin, and olivomycin). Biochemistry (1966) 4.06

Effects of anti-gp120 monoclonal antibodies on CD4 receptor binding by the env protein of human immunodeficiency virus type 1. J Virol (1988) 3.88

Electron microscopy of polar insertions in the lac operon of Escherichia coli. Mol Gen Genet (1972) 3.85

Escherichia coli genome targeting, I. Cre-lox-mediated in vitro generation of ori- plasmids and their in vivo chromosomal integration and retrieval. Gene (1994) 3.84

In vitro packaging of lambda Dam vectors and their use in cloning DNA fragments. Methods Enzymol (1979) 3.82

In vivo excision and amplification of large segments of the Escherichia coli genome. Nucleic Acids Res (1994) 3.61

Polar mutations in lac, gal and phage lambda consist of a few IS-DNA sequences inserted with either orientation. Mol Gen Genet (1972) 3.59

A comprehensive molecular map of bacteriophage lambda. Gene (1979) 3.46

Deletions and insertions in the immunity region of coliphage lambda: revised measurement of the promoter-startpoint distance. Virology (1974) 3.44

Structure and function of the phage lambda att site: size, int-binding sites, and location of the crossover point. Cold Spring Harb Symp Quant Biol (1981) 2.99

Virus-assisted mapping of neural inputs to a feeding center in the hypothalamus. Science (2001) 2.98

Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees. Nature (1987) 2.82

Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival. J Virol (1997) 2.81

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations. Nat Med (1999) 2.77

Asymmetric distribution of the transcribing regions on the complementary strands of coliphage lambda DNA. Proc Natl Acad Sci U S A (1967) 2.70

Human immunodeficiency virus-like, nonreplicating, gag-env particles assemble in a recombinant vaccinia virus expression system. J Virol (1990) 2.58

Identification of OmpR: a positive regulatory protein controlling expression of the major outer membrane matrix porin proteins of Escherichia coli K-12. J Bacteriol (1981) 2.36

Safer derivatives of bacteriophage lambdagt-lambdaC for use in cloning of recombinant DNA molecules. Nature (1976) 2.35

Chemical and enzymatic biotin-labeling of oligodeoxyribonucleotides. Nucleic Acids Res (1985) 2.29

Nomenclature of transposable elements in prokaryotes. Plasmid (1979) 2.17

Patterns of interaction between polyribonucleotides and individual DNA strands derived from several vertebrates, bacteria and bacteriophages. J Mol Biol (1966) 2.13

Electron micrographic maps of deletions and substitutions in the genomes of transducing coliphages lambda dg and lambda bio. Virology (1969) 2.04

Coliphage lambdanutL-: a unique class of mutants defective in the site of gene N product utilization for antitermination of leftward transcription. J Mol Biol (1978) 2.00

Expression of AIDS virus envelope gene in recombinant vaccinia viruses. Nature (1986) 1.98

Pyrimidine clusters on the transcribing strand of DNA and their possible role in the initiation of RNA synthesis. Cold Spring Harb Symp Quant Biol (1966) 1.96

A simple method for identifying the palindromic sequences recognized by restriction endonucleases: the nucleotide sequence of the AvaII site. Gene (1978) 1.91

An epidemic of hepatitis A attributable to the ingestion of raw clams in Shanghai, China. J Infect Dis (1991) 1.90

Translational control of SV40 T antigen expressed from the adenovirus late promoter. Cell (1983) 1.90

Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile. Immunol Lett (1996) 1.87

Universal restriction endonucleases: designing novel cleavage specificities by combining adapter oligodeoxynucleotide and enzyme moieties. Gene (1985) 1.85

Identification of palindromic sequences recognized by restriction endonucleases, as based on the tabularized sequencing data for seven viral and plasmid DNAs. Gene (1980) 1.82

Controls and polarity of transcription during bacteriophage T4 development. J Mol Biol (1971) 1.77

Site-specific insertion of DNA into a pseudorabies virus vector. Proc Natl Acad Sci U S A (1987) 1.77

Fractionation of the complementary strands of coliphage T4 DNA based on the asymmetric distribution of the poly U and poly U,G binding sites. Virology (1968) 1.75

Control of short leftward transcripts from the immunity and ori regions in induced coliphage lambda. Mol Gen Genet (1973) 1.74

Cleaving yeast and Escherichia coli genomes at a single site. Science (1990) 1.70

Proliferative and cytotoxic T cells to AIDS virus glycoproteins in chimpanzees immunized with a recombinant vaccinia virus expressing AIDS virus envelope glycoproteins. J Immunol (1987) 1.63

AIDS vaccine development. Science (1998) 1.62

Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in Macaques. J Virol (1999) 1.60

Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein. Proc Natl Acad Sci U S A (1993) 1.58

Patterns of convergent and overlapping transcription within the b2 region of coliphage lambda. Virology (1969) 1.58

Role of the cro gene in bacteriophage lambda development. J Mol Biol (1973) 1.58

Improved derivative of a phage lambda EK2 vector for cloning recombinant DNA. Nature (1976) 1.56

T-cell responses to human AIDS virus in macaques immunized with recombinant vaccinia viruses. Nature (1986) 1.55

Suppression of RNA precipitation during Cs2SO4 density gradient centrifugation. Biochem Biophys Res Commun (1966) 1.54

Analysis of the sites of integration of viral DNA sequences in rat cells transformed by adenovirus 2 or SV40. Cold Spring Harb Symp Quant Biol (1980) 1.52

Orientation of transcription of the lac operon and its repressor gene in Escherichia coli. J Mol Biol (1969) 1.52

Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen. Proc Natl Acad Sci U S A (1991) 1.47

Packaging of plasmid DNA containing the cohesive ends of coliphage lambda. Gene (1980) 1.45

GENETIC INTERACTION AMONG STREPTOMYCETES: HETEROKARYOSIS AND SYNKARYOSIS. Proc Natl Acad Sci U S A (1957) 1.43

Insertion sequence IS2 associated with int-constitutive mutants of bacteriophage lambda. Gene (1977) 1.43

ColE1 cloning of a ribosomal RNA promoter region from lambdarifd18 by selection for lambda integration and excision functions. Gene (1977) 1.43

Orientation and control of transcription in E. coli phage lambda. Nature (1969) 1.43

Physical and biological consequences of interactions between integration host factor (IHF) and coliphage lambda late p'R promoter and its mutants. Gene (1989) 1.42

Functional roles of the V3 hypervariable region of HIV-1 gp160 in the processing of gp160 and in the formation of syncytia in CD4+ cells. Virology (1992) 1.40

Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting. J Virol (1998) 1.39

Control of cloned gene expression by promoter inversion in vivo: construction of improved vectors with a multiple cloning site and the Ptac promoter. Gene (1987) 1.39

Limited breadth of the protective immunity elicited by simian immunodeficiency virus SIVmne gp160 vaccines in a combination immunization regimen. J Virol (1999) 1.37

Cleaving DNA at any predetermined site with adapter-primers and class-IIS restriction enzymes. Science (1988) 1.37

DNA base composition of Neisseria, Moraxella, and Acinetobacter, as determined by measurement of buoyant density in CsCl gradients. Can J Microbiol (1969) 1.37

Preparing and using agarose microbeads. Methods Enzymol (1992) 1.34

Regulation of integration by coliphage lambda: activation of int transcription by the cII and cIII proteins. Virology (1979) 1.29

Distance from a promoter mutation to an RNA synthesis startpoint on bacteriophage lambda DNA. Nat New Biol (1972) 1.26

Mosaics of gene variations in the Interleukin-10 gene promoter affect interleukin-10 production depending on the stimulation used. Genes Immun (2004) 1.25

Transcriptional controls in developing bacteriophages. J Cell Physiol (1969) 1.25

A relationship between DNA helix stability and recognition sites for RNA polymerase. Science (1979) 1.23

Candidate vaccines protect macaques against primate immunodeficiency viruses. AIDS Res Hum Retroviruses (1998) 1.22

Initiation and patterns of transcription during phage development. Proc Can Cancer Conf (1969) 1.22

Orientation of transcription for the galactose operon as determined by hybridization of gal mRNA with the separated DNA strands of coliphages lambda-dg. J Mol Biol (1968) 1.21

The sequences of and distance between two cis-acting signals determine the efficiency of ribosomal frameshifting in human immunodeficiency virus type 1 and human T-cell leukemia virus type II in vivo. J Virol (1994) 1.20

The genome of Shope fibroma virus, a tumorigenic poxvirus, contains a growth factor gene with sequence similarity to those encoding epidermal growth factor and transforming growth factor alpha. Mol Cell Biol (1987) 1.19

Controls of rightward transcription in coliphage lambda. J Mol Biol (1970) 1.19

A simple technique for the isolation of deletion mutants of phage lambda. Gene (1979) 1.19

Expression of the human immunodeficiency virus gag gene in insect cells. Virology (1987) 1.19

RecA-AC: single-site cleavage of plasmids and chromosomes at any predetermined restriction site. Nucleic Acids Res (1992) 1.18

Induction of cytotoxic T lymphocytes specific for a syngeneic tumor expressing the E6 oncoprotein of human papillomavirus type 16. J Immunol (1992) 1.18

Conferring operator specificity on restriction endonucleases. Science (1988) 1.17

Physical mapping of the att-N region of coliphage lambda: apparent oversaturation of coding capacity in the gam-ral segment. Biochimie (1974) 1.15

Early postinfection antiviral treatment reduces viral load and prevents CD4+ cell decline in HIV type 2-infected macaques. AIDS Res Hum Retroviruses (1997) 1.15

Conversion of the FokI endonuclease to a universal restriction enzyme: cleavage of phage M13mp7 DNA at predetermined sites. Gene (1985) 1.15

Translation of gag, pro, and pol gene products of human T-cell leukemia virus type 2. J Virol (1989) 1.15

Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.15

Organization of ribosomal protein genes in Escherichia coli. I. Physical structure of DNA from transducing lambda phages carrying genes from the aroE-str region. J Mol Biol (1976) 1.15

A family of removable cassettes designed to obtain antibiotic-resistance-free genomic modifications of Escherichia coli and other bacteria. Gene (2000) 1.14

Carbohydrate determinant NeuAc-Gal beta (1-4) of N-linked glycans modulates the antigenic activity of human immunodeficiency virus type 1 glycoprotein gp120. J Gen Virol (1992) 1.13

Mutations and decreases in density of transforming DNA produced by derivatives of the carcinogens 2-acetyl-aminofluorene and N-methyl-4-aminoazobenzene. Mol Pharmacol (1968) 1.13

Processing of the major leftward mRNA of coliphage lambda. Virology (1976) 1.11

Protection of macaques against intrarectal infection by a combination immunization regimen with recombinant simian immunodeficiency virus SIVmne gp160 vaccines. J Virol (1999) 1.11

Sequence homology between bovine and human adenoviruses. J Virol (1984) 1.09